Viridian Therapeutics, Inc.VRDNNASDAQ
Loading
Interest Income Over TimeContracting
Percentile Rank92
3Y CAGR+77.3%
5Y CAGR+175.4%
Year-over-Year Change
Income earned from interest-bearing assets
3Y CAGR
+77.3%/yr
vs +40.7%/yr prior
5Y CAGR
+175.4%/yr
Recent deceleration
Acceleration
+36.6pp
Accelerating
Percentile
P92
Near historical high
vs 5Y Ago
158.4x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $27.40M | -14.7% |
| 2024 | $32.13M | +73.1% |
| 2023 | $18.56M | +277.6% |
| 2022 | $4.92M | +1445.9% |
| 2021 | $318000.00 | +83.8% |
| 2020 | $173000.00 | -81.6% |
| 2019 | $941000.00 | -25.0% |
| 2018 | $1.25M | +211.2% |
| 2017 | $403000.00 | - |
| 2016 | $0.00 | - |